Evidence check: Testosteron Test in the context of menopause

Testing testosterone in the context of menopause is scientifically debated. While declining free testosterone may contribute to low libido and fatigue in some women, reference ranges for females are poorly established, and symptoms often overlap with other menopausal changes. Direct-to-consumer testosterone tests are available, but their clinical utility is limited: levels fluctuate diurnally and across the menstrual cycle, and a single measurement rarely guides therapy. Evidence for testosterone therapy in menopause is moderate for hypoactive sexual desire disorder, but long-term safety data (cardiovascular, breast cancer) are lacking. Most guidelines recommend symptom-driven assessment rather than routine testing. Therefore, a standalone testosterone test without medical context is of low predictive value. Evidence level: mixed – mechanistic plausibility and some human studies exist, but no strong consensus for population screening. Consumers should be cautious about overinterpreting results from home tests.